The Need of Non-traditional Techniques to Screen for the Virus
DOI:
https://doi.org/10.3889/oamjms.2020.4773Keywords:
COVID-19, Coronavirus, MetagenomicsAbstract
BACKGROUND: At the present moment, the etiological diagnosis of SARS-CoV-2 is based on the polymerase chain reaction (PCR). False negative cases are increasingly reported in several studies using reverse transcription-PCR (RT-PCR). For example, the positive rate of RT-PCR for throat swabs was reported to be about 60% in early stage of COVID-19.
AIM: We aimed to present metagenomic next-generation sequencing (mNGS) as a potential tool to detect pathogens.
METHODS: In the recent year, mNGS is shown the potential to detect pathogens without the need of hypothesis guided approach and is proven to be highly effective.
RESULTS: A recent prospective study in the United States compared the diagnostic performance of routine diagnostic tests with mNGS and showed that mNGS detected a bacteria or virus in the CSF of 13 of 58 patients presenting with meningoencephalitis who were negative for or not assessed with routine diagnostic test including PCR. NGS also has the advantage to cover entire viral genomes.
CONCLUSION: As viral metagenomics has significantly improved in recent years and become more cost effective, we think that a change in the approach toward a shot-gun metagenomic testing should be explored and could potentially aid the diagnosis of COVID-19 cases and the management of this pandemic.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Callaway E, Cyranoski D. New China virus: Five questions scientists are asking. Nature. 2020;577(7792):4.
Salathe M, Althaus CL, Neher R, Stringhini S, Hodcroft E, Fellay J, et al. COVID-19 epidemic in Switzerland: On the importance of testing, contact tracing and isolation. Swiss Med Wkly. 2020;150:w20225. https://doi.org/10.4414/ smw.2020.20225 PMid:32191813
Li JO, Lam DS, Chen Y, Ting DS. Novel coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020;104(3):297-8. https://doi.org/10.1136/ bjophthalmol-2020-315994 PMid:32086236
He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020 Mar 14. doi: 10.1002/jmv.25766. [Epub ahead of print] Review. PubMed PMID:32170865.
Parekh M, Borroni D, Romano V, Kaye SB, Camposampiero D, Ponzin D, et al. Next-generation sequencing for the detection of microorganisms present in human donor corneal preservation medium. BMJ Open Ophthalmol. 2019;4(1):e000246. https:// doi.org/10.1136/bmjophth-2018-000246 PMid:31179394
Gallon P, Parekh M, Ferrari S, Fasolo A, Ponzin D, Borroni D. Metagenomics in ophthalmology: Hypothesis or real prospective? Biotechnol Rep (Amst). 2019;23:e00355. https:// doi.org/10.1016/j.btre.2019.e00355 PMid:31312608
Borroni D, Romano V, Kaye SB, Somerville T, Napoli L, Fasolo A, et al. Metagenomics in ophthalmology: Current findings and future prospectives. BMJ Open Ophthalmol. 2019;4(1):e000248. https://doi.org/10.1136/bmjophth-2018-000248.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Davide Borroni, Kunal Gadhvi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0